@article{article, title = {{Laboratory Parameters in Adolescent Patients Aged 12鈥�17 with Moderate-to-Severe Atopic Dermatitis Treated with Tralokinumab Up to Week 52: Results from the Phase 3 ECZTRA 6 Trial}}, publisher = {{National Society for Cutaneous Medicine}}, url = {{http://dx.doi.org/10.25251/skin.8.supp.323 }}, year = {{2024}}, month = {{1}}, author = {{Paller A and Cork M and Hong C-H and Soong W and Schneider S and Lo H and Pedersen LRM and Vacko E and Wollenberg A}}, doi = {{10.25251/skin.8.supp.323}}, volume = {{8}}, journal = {{SKIN The Journal of Cutaneous Medicine}}, issue = {{1}}, pages = {{s323-s323}}, note = {{Accessed on 2025/05/23}}}